Promacta: Medgend

Promacta FDA Approved Drugs

PROMACTA [Eltrombopag Olamine^{C₂₅H₂₂N₄O₄2C₂H₇NO}]

eq 100mg acid (oral tablet)

eq 12.5mg acid (oral tablet)

eq 25mg acid (oral tablet)

eq 25mg acid/packet (oral for suspension)

eq 50mg acid (oral tablet)

eq 75mg acid (oral tablet)

Novartis Pharms Corp^{Nov 16, 2012}

Patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.
Topical treatment of interdigital tinea pedis and tinea corporis due to trichophyton rubrum, trichophyton mentagrophytes or epidermophyton floccosum.
Treatment of idiopathic thrombocytopenic purpura (itp).
Treatment of immune (idiopathic) thrombocytopenia (itp).
Treatment of thrombocytopenia in adult and pediatric patients 6 years and older with chronic immune (idiopathic) thrombocytopenia (itp).
Treatment of thrombocytopenia in patients with chronic hepatitis c to allow the initiation and maintenance of interferon-based therapy.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.